Compare PGEN & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | CXM |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2013 | 2021 |
| Metric | PGEN | CXM |
|---|---|---|
| Price | $3.81 | $5.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | ★ $8.33 | $8.28 |
| AVG Volume (30 Days) | ★ 4.0M | 3.1M |
| Earning Date | 05-13-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $230,981,000.00 | ★ $857,200,000.00 |
| Revenue This Year | $1,115.92 | $2.52 |
| Revenue Next Year | $81.04 | $4.94 |
| P/E Ratio | ★ N/A | $62.44 |
| Revenue Growth | N/A | ★ 7.64 |
| 52 Week Low | $1.30 | $4.72 |
| 52 Week High | $5.47 | $9.40 |
| Indicator | PGEN | CXM |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 50.08 |
| Support Level | $3.49 | $5.19 |
| Resistance Level | $4.40 | $5.60 |
| Average True Range (ATR) | 0.29 | 0.25 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 2.97 | 45.76 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.